Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
The Journal of Headache and Pain
Published in: The Journal of Headache and Pain 1/2014

Open Access 01-12-2014 | Meeting abstract

EHMTI-0133. Does medication overuse matter? Response to botulinum toxin type A in chronic migraine in patients with or without medication overuse

Authors: H Zafar, M Khalil, F Ahmed

Published in: The Journal of Headache and Pain | Special Issue 1/2014

Login to get access

Excerpt

Chronic migraine (CM) affects 2% of the general population with substantial impact on quality of life. Chronic headache with medication overuse prevalence is about 65% in specialised-headache-centres based studies . Medication overuse (MO), by the International Headache Study definition, is different to Medication overuse headache (MOH) . There is no consensus as to whether pharmacological prophylaxis should be initiated once MO has been treated or both could be done simultaneously . Topiramate efficacy was found to be not affected by medication overuse, moreover the PREEMPT data also indicated a similar response between the two groups. …
Metadata
Title
EHMTI-0133. Does medication overuse matter? Response to botulinum toxin type A in chronic migraine in patients with or without medication overuse
Authors
H Zafar
M Khalil
F Ahmed
Publication date
01-12-2014
Publisher
Springer Milan
Published in
The Journal of Headache and Pain / Issue Special Issue 1/2014
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI
https://doi.org/10.1186/1129-2377-15-S1-G18

Other articles of this Special Issue 1/2014

The Journal of Headache and Pain 1/2014 Go to the issue

Meeting abstract

EHMTI-0237. The A11 hypothalamic nucleus is susceptible to nitric oxide signalling

Meeting abstract

EHMTI-0213. Does prior craniofacial nociception lead to an increase in cortical excitability?

Meeting abstract

EHMTI-0132. Premonitory symptoms and migraine disability assessment (MIDAS) questionnaire

Meeting abstract

EHMTI-0379. Update of the uk post market pilot programme with single pulse transcranial magnetic stimulation (STMS) for the acute treatment of migraine

Meeting abstract

EHMTI-0135. Migraine outcomes and cortical excitability: analysis of pattern-reversal visual evoked potentials (PR-VEP)

Meeting abstract

EHMTI-0121. The disturbances of reactivity of cerebral vessels in patients with posttraumatic headaches